Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles

Acta Biomaterialia(2023)10.1016/j.actbio.2023.09.001Source: DataRank Database

High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles is a research paper published in Acta Biomaterialia (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 1.48)OA: hybridTopics (37)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Lorena Alba‐Castellón ORCID,Naroa Serna ORCID,Isolda Casanova ORCID,Hèctor López‐Laguna ORCID,Alberto Gallardo ORCID

Live enrichment

PubMed:37683965 OpenAlex:https://openalex.org/W4386485238

National Institutes of Health

Grant: R01-GM129325

Ministerio de Ciencia e Innovación

Grant: FPU18/04615

Agència de Gestió d'Ajuts Universitaris i de Recerca

Grant: 2019FI_B00352

Agència de Gestió d'Ajuts Universitaris i de Recerca

Grant: SGR2021 00092

Agència de Gestió d'Ajuts Universitaris i de Recerca

Grant: SGR2021 01140

Instituto de Salud Carlos III

Grant: P21/00150

Instituto de Salud Carlos III

Grant: PI20/00400

Generalitat de Catalunya

Grant: CP19/00028

European Social Fund

Fundación Científica Asociación Española Contra el Cáncer

Center for International Business Education and Research, University of Illinois at Urbana-Champaign

European Regional Development Fund

Institució Catalana de Recerca i Estudis Avançats

National Institute of Allergy and Infectious Diseases

FWCI

1.48

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://ars.els-cdn.com/content/image/1-s2.0-S1742706123005263-ga1_lrg.jpg

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S1742706123005263-ga1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S1742706123005263?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1742706123005263?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.actbio.2023.09.001

Fields of Study

Cancer Research and TreatmentsNanoplatforms for cancer theranosticsBacteriophages and microbial interactions

MeSH Terms

Cancer-Associated FibroblastsAnimalsFemaleHumansDrug Delivery SystemsReceptor, Platelet-Derived Growth Factor betaCell Line, TumorGreen Fluorescent ProteinsMiceNanoparticles

Keywords

Stromal cellCancer researchDrug deliveryCancer-Associated FibroblastsCancer cellPlatelet-derived growth factor receptorGrowth factor receptorCancerMaterials sciencePancreatic cancerTargeted drug deliveryReceptorGrowth factorNanotechnologyChemistryBiologyMedicineBiochemistryInternal medicineNanoparticlesNanomedicineCell TargetingProtein MaterialsPrecision Medicines

Sustainable Development Goals

SDG 0: Good health and well-being